Hormone replacement therapy and cancer risk

Current Opinion in Oncology

Volumn 13, Issue 5, 2001, Pages 384-389

  Mahavni, Vikas ^a   Sood, Anil K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE; PROGESTERONE DERIVATIVE;

BREAST CANCER; CANCER MORTALITY; CANCER RISK; CLINICAL TRIAL; COLON CANCER; DRUG UTILIZATION; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; COLONIC NEOPLASMS; ENDOMETRIAL NEOPLASMS; EPIDEMIOLOGIC STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; OVARIAN NEOPLASMS; PROGESTINS; RECTAL NEOPLASMS; RISK FACTORS;

EID: 0034865794     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200109000-00012     Document Type: Review

References (29)

1. Cancer Statistics 2000
2. On the treatment of inoperable carcinoma of the mamma: Suggestions for a new method of treatment, with illustrative cases
3. Breast cancer risk after bilaterel prophylectic oophorectomy in BRCA1 mutation carriers
4. Testosterone inhibits estrogen induced mammary epithelial proliferation and suppresses estrogen receptor expression
5. Incidence of breast cancer in a 22 year study of women receiving estrogen-progesterone replacement therapy
6. Hormone replacement therapy and breast cancer in e nationally representative cohort
7. Menopausel hormone breast cancer in a biracial population
8. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
9. Menopausal estrogen an estrogen-progestin replacement therapy and breast cancer risk
10. Role of hormones in mammary cancer initiation and progression
11. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women
12. Hormone replacement therapy in menopause and risk of breast cancer
13. Association of exogenous estrogen and endometrial carcinoma
14. Increased risk of endometrial cancer among users of conjugated estrogen
15. The prevention of endometrial cancer in postmenopausal women with progestogens
16. Continuous combined hormone replacement therapy and risk of endometrial cancer
17. Progestins and menopause: Epidemiological studies of risk of endometrial and breast cancer
18. Hormone replacement therapy and endometrial cancer in Ontario, Canada
19. Reproduction, endogenous and exogenous sex hormone and colon cancer: A review and hypothesis
20. A case control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer
21. Hormone replacement and the risk of colorectal cancer: A meta-analysis
22. Epithelial ovarian cancer
23. The estimated effect of oral contraceptive use in the cumulative risk of epithelial ovarian cancer
24. Oral contraceptives and the risk of heriditary ovarian cancer
25. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
26. Estrogen replacement therapy and fatal ovarian cancer
27. Estrogen replacement therapy and risk of epithelial ovarian cancer
28. Noncontraceptive estrogen use and epithelial ovarian cancer
29. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case control study